Miyashita M, Koga K, Izumi G, Sue F, Makabe T, Taguchi A, et al
The protective action of follicle stimulating hormone on embryonic development is largely due to glutathione synthesis (Tsai-Turton & Luderer, 2006)
But a recent mouse study showed that semaglutide doesnt really target these preproglucagon neurons and instead acts more on the peripheral systems.[ref] GLP-1 receptors are also found on pancreatic beta cells, triggering insulin release
All compounds are strictly intended for research use only (RUO) and are not approved for human medical or therapeutic use
42) In SUSTAIN-6, patients treated with semaglutide had a lower risk of developing or worsening nephropathy, but a higher risk of complications from diabetic retinopathy than those receiving placebo ( In subsequent studies: PIONEER-6 and ELIXA the primary endpoints (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, hospitalization for unstable angina) were not met in the GLP-1 RAs group, but a significant decrease in glycated hemoglobin was observed